News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
56,254 Results
Type
Article (4894)
Company Profile (17)
Press Release (51341)
Multimedia
Podcasts (1)
Webinars (4)
Section
Business (17040)
Career Advice (264)
Deals (2650)
Drug Delivery (11)
Drug Development (2907)
Employer Resources (23)
FDA (1113)
Job Trends (1696)
News (24072)
Policy (2123)
Tag
Academia (561)
Allergies (3)
Alliances (5764)
ALS (6)
Alzheimer's disease (135)
Antibody-drug conjugate (ADC) (24)
Approvals (1128)
Artificial intelligence (122)
Autoimmune disease (13)
Automation (22)
Bankruptcy (24)
Best Places to Work (1174)
BIOSECURE Act (1)
Biosimilars (26)
Biotechnology (8)
Bladder cancer (3)
Brain cancer (4)
Breast cancer (34)
Cancer (323)
Cardiovascular disease (29)
Career advice (235)
Career pathing (12)
CAR-T (15)
CDC (2)
Cell therapy (50)
Cervical cancer (11)
Clinical research (2000)
Collaboration (229)
Compensation (8)
Complete response letters (1)
COVID-19 (436)
CRISPR (13)
C-suite (63)
Cystic fibrosis (9)
Data (316)
Denatured (1)
Depression (4)
Diabetes (16)
Diagnostics (1828)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (47)
Drug pricing (6)
Drug shortages (2)
Duchenne muscular dystrophy (3)
Earnings (4621)
Editorial (3)
Employer branding (2)
Employer resources (21)
Events (5948)
Executive appointments (88)
FDA (1282)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (189)
Gene editing (22)
Generative AI (10)
Gene therapy (35)
GLP-1 (61)
Government (476)
Grass and pollen (1)
Guidances (24)
Healthcare (1529)
HIV (6)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (14)
Immuno-oncology (4)
Indications (2)
Infectious disease (472)
Inflammatory bowel disease (15)
Influenza (33)
Intellectual property (11)
Interviews (34)
IPO (902)
IRA (4)
Job creations (515)
Job search strategy (199)
JPM (11)
Labor market (20)
Layoffs (43)
Leadership (15)
Legal (353)
Liver cancer (2)
Longevity (3)
Lung cancer (32)
Lymphoma (25)
Machine learning (15)
Management (5)
Manufacturing (108)
MASH (2)
Medical device (1014)
Medtech (1019)
Mergers & acquisitions (1841)
Metabolic disorders (45)
Multiple sclerosis (6)
Neurodegenerative disease (19)
Neuropsychiatric disorders (3)
Neuroscience (218)
Neurotech (1)
NextGen: Class of 2026 (718)
Non-profit (550)
Now hiring (19)
Obesity (26)
Opinion (55)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (12)
Parkinson's disease (25)
Partnered (9)
Patents (19)
Patient recruitment (16)
Peanut (3)
People (4858)
Pharmaceutical (2)
Phase 1 (726)
Phase 2 (885)
Phase 3 (693)
Pipeline (439)
Policy (13)
Postmarket research (91)
Preclinical (510)
Press Release (18)
Prostate cancer (21)
Psychedelics (5)
Radiopharmaceuticals (13)
Rare diseases (38)
Real estate (1443)
Recruiting (13)
Regulatory (1555)
Reports (11)
Research institute (531)
Resumes & cover letters (31)
Rett syndrome (3)
RNA editing (1)
RSV (6)
Schizophrenia (7)
Series A (35)
Series B (20)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (5)
Sponsored (8)
Startups (502)
Stomach cancer (1)
Supply chain (11)
Tariffs (4)
Vaccines (44)
Venture capital (19)
Weight loss (15)
Women's health (10)
Worklife (5)
Date
Last 7 days (43)
Last 30 days (161)
Last 365 days (2175)
2026 (209)
2025 (2200)
2024 (2718)
2023 (3286)
2022 (4740)
2021 (4994)
2020 (5648)
2019 (4214)
2018 (3015)
2017 (2938)
2016 (3143)
2015 (3161)
2014 (2180)
2013 (1940)
2012 (2075)
2011 (2186)
2010 (1619)
Location
Africa (108)
Alabama (10)
Alaska (1)
Arizona (28)
Arkansas (1)
Asia (3155)
Australia (419)
California (786)
Canada (233)
China (77)
Colorado (38)
Connecticut (93)
Delaware (15)
Europe (6281)
Florida (61)
Georgia (26)
Idaho (5)
Illinois (56)
India (13)
Indiana (62)
Iowa (7)
Japan (24)
Kansas (6)
Kentucky (3)
Louisiana (3)
Maine (6)
Maryland (86)
Massachusetts (558)
Michigan (87)
Minnesota (44)
Mississippi (1)
Missouri (29)
Montana (4)
Nebraska (5)
Nevada (10)
New Hampshire (9)
New Jersey (174)
New Mexico (11)
New York (230)
North Carolina (116)
North Dakota (3)
Northern California (382)
Ohio (61)
Oklahoma (3)
Oregon (8)
Pennsylvania (160)
Rhode Island (3)
South America (190)
South Carolina (8)
Southern California (275)
Tennessee (40)
Texas (132)
United States (2997)
Utah (53)
Virginia (19)
Washington D.C. (4)
Washington State (77)
West Virginia (2)
Wisconsin (21)
56,254 Results for "shattuck labs".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 15, 2025
December 16, 2025
·
1 min read
Press Releases
Shattuck Labs Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 6, 2025
·
9 min read
Press Releases
Shattuck Labs Announces Participation in Upcoming Wedbush Securities Key Opinion Leader (KOL) and Company Panel
October 3, 2025
·
2 min read
Press Releases
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
August 22, 2025
·
5 min read
Press Releases
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
August 26, 2025
·
8 min read
Press Releases
Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million
August 6, 2025
·
8 min read
Press Releases
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
August 15, 2025
·
10 min read
Layoffs
Shattuck Labs to Lay Off 40% of Workforce
As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.
October 1, 2024
·
2 min read
·
Angela Gabriel
Press Releases
Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism
July 3, 2025
·
1 min read
Press Releases
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 1, 2025
·
10 min read
1 of 5,626
Next
